Skip to main content
Search
Search
India | en
Choose Location
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
Brazil |
Português
Canada |
English
Canada |
Français
Central America |
Español
Colombia |
Español
Mexico |
Español
United States |
English
Australia |
English
Bangladesh |
English
Hong Kong S.A.R. |
繁體中文
India |
English
Indonesia |
English
Japan |
日本語
Korea |
한국어
Mainland China |
中文
Malaysia |
English
Pakistan |
English
Philippines |
English
Singapore |
English
Taiwan |
繁體中文
Thailand |
ภาษาไทย
Austria |
Deutsch
Belgium |
Français
Belgium |
Nederlands
Bulgaria |
Български
Czech Republic |
Česky
Czech Republic |
English
Denmark |
Dansk
Estonia |
Eesti
Finland |
Suomalainen
France |
Français
Germany |
Deutsch
Greece |
Ελληνικά
Hungary |
Magyar
Ireland |
English
Italy |
Italiano
Latvia |
Latvian
Lithuania |
Lithuanian
Netherlands |
Nederlands
Norway |
Norsk
Poland |
Polski
Portugal |
Português
Romania |
Română
Russia |
Русский
Serbia |
Srpski
Slovakia |
Slovensky
Slovenia |
Slovenščina
Slovenia |
English
Spain |
Español
Sweden |
Svenska
Switzerland |
Deutsch
Switzerland |
Français
Türkiye |
Türkçe
United Kingdom |
English
Global |
English
Novartis Foundation |
English
Egypt |
English
Israel |
עברית
Saudi Arabia |
العربية
South Africa |
English
India
Choose Location
asia-pacific
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
Australia |
English
Austria |
Deutsch
Bangladesh |
English
Belgium |
Français
Belgium |
Nederlands
Brazil |
Português
Bulgaria |
Български
Canada |
English
Canada |
Français
Central America |
Español
Colombia |
Español
Czech Republic |
Česky
Czech Republic |
English
Denmark |
Dansk
Egypt |
English
Estonia |
Eesti
Finland |
Suomalainen
France |
Français
Germany |
Deutsch
Greece |
Ελληνικά
Hong Kong S.A.R. |
繁體中文
Hungary |
Magyar
India |
English
Indonesia |
English
Ireland |
English
Israel |
עברית
Italy |
Italiano
Japan |
日本語
Korea |
한국어
Latvia |
Latvian
Lithuania |
Lithuanian
Mainland China |
中文
Malaysia |
English
Mexico |
Español
Netherlands |
Nederlands
Norway |
Norsk
Global |
English
Novartis Foundation |
English
Pakistan |
English
Philippines |
English
Poland |
Polski
Portugal |
Português
Romania |
Română
Russia |
Русский
Saudi Arabia |
العربية
Serbia |
Srpski
Singapore |
English
Slovakia |
Slovensky
Slovenia |
Slovenščina
Slovenia |
English
South Africa |
English
Spain |
Español
Sweden |
Svenska
Switzerland |
Deutsch
Switzerland |
Français
Taiwan |
繁體中文
Thailand |
ภาษาไทย
Türkiye |
Türkçe
United Kingdom |
English
United States |
English
Menu
About
Novartis in India
Development
Diversity and Inclusion
People and Culture
Arogya Parivar
India Country Leadership Team
NIL Board of Directors
Mr. Christopher Snook
Mr. Sanjay Murdeshwar
Mr. Jai Hiremath
Ms. Sandra Martyres
Ms. Monaz Noble
Mr. Sanker Parameswaran
Ms. Shilpa Joshi
Contact Us
About
Patients and Caregivers
Novartis Commitment to Patients and Caregivers
Diseases
Adverse Event Reporting
Patients and Caregivers
Healthcare Professionals
Healthcare professional country resource
Novartis Pipeline
Adverse Event Reporting
Novartis Clinical Trials
Healthcare Professionals
ESG
Ethical Behavior
Code of Ethics
SpeakUp
Ethics, Risk and Compliance
Access
Environmental Sustainability
Global Health
ESG
Investors | Corporate Governance
Shareholders' Information
Annual General Meeting
Corporate Policies
Financials
Stock Exchange Disclosures
Transfer of Shares to IEPF Demat Account
Novartis India Investors Contact
Novartis India Annual General Meeting
Novartis India Board of Directors
Novartis India Investors | Corporate Governance
News
News Archive
Contacts
News
Careers
Career Search
BioCamp
Meet the teams
Personal Growth
Early Talent
Well-being
Diversity and Inclusion
Awards and Recognition
Careers
Coronavirus
Coronavirus
Home
Home
Careers
Career Search
Function
Audit & Finance
BD&L & Strategic Planning
Commercial & General Management
Communications & Public Affairs
Data Science
Facilities & Administration
Human Resources
Information Technology
Interns/Students on Novartis Payroll
Legal & Intellectual Property & Compl.
Market Access
Marketing
Procurement
Quality
Research & Development
Sales
Technical Operations
Third Party Associate
Under Evaluation
Location
Albania
Algeria
Angola
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Benin
Bermuda
Bolivia
Bosnia and Herzegovina
Brazil
Bulgaria
Burkina Faso
Cameroon
Canada
Chile
China
Colombia
Costa Rica
Croatia
Curacao
Cyprus
Czech Republic
Democratic Republic of the Congo
Denmark
Dominican Republic
Ecuador
Egypt
El Salvador
Estonia
Ethiopia
Finland
France
Gabon
Georgia
Germany
Ghana
Greece
Guatemala
Guinea
Honduras
Hong Kong Special Administrative Region, China
Hungary
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kuwait
Kyrgyzstan
Latvia
Lebanon
Lithuania
Luxembourg
Macao Special Administrative Region, China
Macao Special Administrative Region, China
Macedonia
Malaysia
Mali
Malta
Mauretania
Mexico
Moldova
Morocco
Myanmar
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palestine
Panama
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Republic of the Congo
Romania
Russian Fed.
Saudi Arabia
Senegal
Serbia/Monten.
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Thailand
Togo
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
USA
Ukraine
United Kingdom
Uruguay
Utd.Arab Emir.
Uzbekistan
Vanuatu
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
All
Today
This Week
Last Two Weeks
This Month
Division
Biomedical Research
CTS
Corporate
Corporate Affairs
Development
Ethics Risk & Compliance
Finance
International
Legal
Oncology
Operations
People & Organization
Pharma
Strategy & Growth
US
Show Filters
Date Posted
Date Posted
All
Today
This Week
Last Two Weeks
This Month
Showing 324 results
Sort by
Sort ascending
Job Title
Sort ascending
Business
Location
Site
Date Posted
Job Title
Sort ascending
Business
Location
Site
Date Posted
No content has been found.
Pagination
‹
Previous page
1
…
27
28
29
30
31
32
33